The abstract is read at the publisher; the summary is JClub's.
Honokiol attenuates lipopolysaccharide-induced lung injury and fibrosis in mice by preserving miR-19a-3p and reducing periostin (POSTN) expression.
- Why it matters: ARDS and subsequent pulmonary fibrosis have high mortality and limited treatments, and the miR-19a-3p/POSTN regulatory relevance in this setting is unclear.
- What they did: Serum POSTN and miR-19a-3p were measured in patients with ARDS and correlated with severity; mechanistic work used an LPS mouse model plus macrophage-epithelial and macrophage-fibroblast co-cultures, including dual-luciferase reporter assays.
- The result: ARDS patients showed elevated serum POSTN and reduced miR-19a-3p with inverse, severity-linked correlations; HKL reduced POSTN and preserved miR-19a-3p, and miR-19a-3p loss-of-function suggested it contributes to HKL-associated protection.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.